Aim Diuretics are a cornerstone in treatment of heart failure (HF). Torasemide is a loop
diuretic with a potential advantage over other diuretics. We aim to meta‐analyse and …

Background Diuretics such as torasemide are commonly used to treat chronic heart failure
(CHF). Aims The objective of the TOrasemide In Congestive Heart Failure (TORIC) Study …

Objectives To compare the efficacy and safety of torsemide versus furosemide in patients
with heart failure (HF). Data sources Medline, Cochrane Library, Web of Science, and …

Aims Loop diuretics have become a mainstay of chronic heart failure management.
Furosemide and torsemide are the two most common loop diuretics; nevertheless, there is …

Purpose Current clinical recommendations do not emphasise superiority of any of diuretics,
but available reports are very encouraging and suggest beneficial effects of torasemide. This …

Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart
failure patients: Preliminary result Page 1 Address for correspondence: Michał Marchel, MD …

Purpose Diuretics are the primary treatment for the management of chronic heart failure (HF)
symptoms and for the improvement of acute HF symptoms. The rate of delivery to the site of …

Although torsemide's oral bioavailability and half-life theoretically render it a more efficient
diuretic than furosemide, the clinical outcomes of torsemide compared with furosemide …

Purpose: We aimed to comprehensively evaluate the curative effect of torasemide, tolvaptan,
furosemide and azosemide on patients with heart failure. Methods: Relevant studies were …

Background: The hypothesis was that torasemide, due to more predictable
pharmacokinetics/pharmacodynamics, induces greater improvements in functional and …